Pediatric drugs refer to a class of drugs designed to suit the special physiology and needs of children, who, as a special group, are significantly different from adults in terms of development and physiology. Overall demand for children's drugs being smaller than that of adult drugs, higher R&D costs, clinical trial recruitment, and ethical issues make the process of pediatric drug development getting more complicated. The current use of pediatric drugs is far from meeting therapeutic needs, coupled with problems like drug abuse and drug use without instructions, which may bring unknown safety risks to children physically and mentally.

The development of drugs for children is of great importance to all of humanity, and TargetMol has collected 972 pediatric drugs, all of which have been approved for pediatric disease treatment or are in clinical trials for pediatric disease treatment, and can be used for pediatric drug development such as functional repositioning of drugs for children.